Piedmont Lithium Inc. Balance Sheet

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD; shares in millions, except per-share amounts

	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q3 FY2021 As of Sep 30, 2021	Q2 FY2021 As of Jun 30, 2021	Q2 FY2020 As of Jun 30, 2020	Q2 FY2019 As of Jun 30, 2019	Q2 FY2018 As of Jun 30, 2018
Cash and cash equivalents
Trade and other receivables
Other assets
Total Current Assets
Exploration and evaluation assets
Property, plant and equipment
Total Non-Current Assets
TOTAL ASSETS
Trade and other payables
Other liabilities
Total Current Liabilities
Total Non-Current Liabilities
TOTAL LIABILITIES
NET ASSETS
Contributed equity
Reserves
Accumulated losses
Assets
Cash and cash equivalents
Accounts receivable
Other current assets
Total current assets
Exploration and evaluation assets
Property, plant and mine development, net
Operating lease right-of-use assets
Advances to affiliates
Other non-current assets
Equity method investments
Total assets

Liabilities and Stockholders’ Equity
Accounts payable and accrued expenses
Accounts payable
Affiliated Entity
Total accounts payable
Accrued expenses
Payables to affiliates
Current debt obligations
Operating lease liabilities
Deferred revenue
Other current liabilities
Total current liabilities
Long-term debt, net of current portion
Operating lease liabilities, net of current portion
Other non-current liabilities
Deferred tax liabilities
Total liabilities
Stockholders’ equity:
Common stock; $0.0001 par value, 100,000,000 shares authorized; 21,946,069 and 21,825,465 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Total stockholders’ equity
Total liabilities and stockholders’ equity
Common stock, shares outstanding (in shares)

Comments